Calumet Specialty Products Partners (CLMT)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ
Market Cap: $3.02B
Last updated: Nov 17, 2026 at 11:05 AM ET
Calumet Specialty Products Partners (CLMT) Financials: Revenue, Profit and Cash Flow
Calumet Specialty Products Partners reported revenue of $4.14B for the fiscal year ended Dec 31, 2025, down 1.2% from the year before. That year, net income was -$33.80M with a net margin of -0.8%, operating cash flow was $108.90M and free cash flow was $56.60M. The quarter ended Sep 30, 2026 had revenue of $1.68B and net income of $256.40M.
Revenue and Margins
The operating margin was 1.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $3.60B, a compound annual rate of 1.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $4.14B | -1.2% | 5.9% | 1.3% | -0.8% |
| Dec 2024 | $4.19B | +0.2% | 5.5% | 0.2% | -5.3% |
| Dec 2023 | $4.18B | -10.8% | 10.8% | 6.4% | 1.2% |
| Dec 2022 | $4.69B | +48.9% | 7.5% | 2.8% | -3.6% |
| Dec 2021 | $3.15B | +38.8% | 4.5% | -2.7% | -8.1% |
| Dec 2020 | $2.27B | -34.3% | 4.4% | -3.2% | -6.6% |
| Dec 2019 | $3.45B | -1.3% | 13.1% | 2.2% | -1.3% |
| Dec 2018 | $3.50B | -7.1% | 12.5% | 3.5% | -1.6% |
| Dec 2017 | $3.76B | +4.6% | 13.2% | 4.2% | -2.8% |
| Dec 2016 | $3.60B | N/A | 11.3% | -1.1% | -9.1% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income fell 18.2% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.14B | $4.19B | $4.18B | $4.69B | $3.15B | $2.27B | $3.45B | $3.50B | $3.76B | $3.60B |
| Cost of revenue | $3.89B | $3.96B | $3.73B | $4.33B | $3.01B | $2.17B | $3.00B | $3.06B | $3.27B | $3.19B |
| Gross profit | $245.70M | $230.80M | $451.70M | $351.70M | $142.90M | $99.10M | $451.70M | $436.70M | $498.20M | $408.30M |
| Operating income | $54.20M | $8.10M | $267.20M | $131.90M | -$85.60M | -$71.90M | $76.30M | $122.90M | $158.00M | -$39.70M |
| Net income | -$33.80M | -$222.00M | $48.10M | -$169.80M | -$254.90M | -$149.00M | -$43.60M | -$55.10M | -$103.80M | -$328.60M |
| EBITDA | $238.40M | $164.50M | $418.20M | N/A | -$1.40M | $83.10M | $201.60M | $236.10M | $306.50M | $50.30M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.68B | $1.45B | $1.03B | $1.04B | $1.08B | $1.03B | $993.90M | $949.50M | $1.10B | $1.13B | $1.13B | $976.90M |
| Gross profit | $543.20M | $18.30M | -$87.50M | -$3.00M | $373.70M | -$43.60M | -$81.40M | $83.60M | $4.90M | $63.80M | $63.80M | $22.00M |
| Operating income | $453.70M | -$40.00M | -$171.30M | -$63.20M | $322.90M | -$101.00M | -$48.70M | $22.70M | -$57.10M | $6.20M | $6.20M | -$12.50M |
| Net income | $256.40M | -$95.90M | -$317.00M | -$37.30M | $313.40M | -$147.90M | -$162.00M | -$40.70M | -$100.60M | -$38.30M | -$38.30M | -$65.20M |
Balance Sheet
As of Dec 2025, total debt of $2.30B exceeded cash and equivalents by $2.17B. Shareholder equity was negative, at -$732.70M, as total liabilities of $3.18B exceeded total assets of $2.69B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.69B | $2.76B | $2.75B | $2.74B | $2.13B | $1.81B | $1.86B | $2.09B | $2.69B | $2.73B |
| Current assets | $857.80M | $766.00M | $794.70M | $819.60M | $632.60M | $534.90M | $512.10M | $670.00M | $1.19B | $640.90M |
| Cash and equivalents | $125.10M | $38.10M | $7.90M | $35.20M | $38.10M | $109.40M | $19.10M | $155.70M | $164.30M | $4.20M |
| Total liabilities | $3.18B | $3.22B | $3.00B | $3.03B | $2.51B | $1.94B | $1.84B | $2.02B | $2.57B | $2.51B |
| Short-term debt | $220.40M | $126.30M | $321.70M | $312.10M | $245.50M | $143.10M | $196.70M | $3.80M | $354.10M | $3.50M |
| Long-term debt | $2.08B | $2.06B | $1.83B | $1.54B | $1.42B | $1.32B | $1.21B | $1.60B | $1.64B | $1.99B |
| Shareholder equity | -$732.70M | -$712.80M | -$491.60M | -$533.60M | -$388.90M | -$137.60M | $9.60M | -$8.70M | $119.90M | $218.70M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.99B | $2.80B | $2.75B | $2.69B | $2.73B | $2.78B | $2.82B | $2.76B | $2.64B | $2.67B | $2.67B | $2.75B |
| Total liabilities | $3.60B | $3.69B | $3.55B | $3.18B | $3.18B | $3.54B | $3.44B | $3.22B | $3.07B | $2.99B | $2.99B | $3.00B |
| Cash and equivalents | $225.20M | $109.80M | $138.60M | $125.10M | $94.60M | $110.60M | $123.40M | $38.10M | $34.60M | $7.00M | $7.00M | $7.90M |
| Shareholder equity | -$870.70M | -$1.14B | -$1.04B | -$732.70M | -$695.30M | -$1.01B | -$862.30M | -$712.80M | -$672.20M | -$566.10M | -$566.10M | -$491.60M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 52.0% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $108.90M | -$46.40M | -$14.90M | $100.60M | -$44.00M | $62.80M | $191.90M | $75.20M | -$26.50M | $4.10M |
| Capital expenditures | $52.30M | $76.70M | $271.80M | $536.20M | $82.90M | $44.00M | $54.90M | $49.80M | $70.00M | $139.40M |
| Free cash flow | $56.60M | -$123.10M | -$286.70M | -$435.60M | -$126.90M | $18.80M | $137.00M | $25.40M | -$96.50M | -$135.30M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 | $52.10M |
| Investing cash flow | $44.10M | -$76.70M | -$271.80M | -$286.00M | -$82.80M | -$46.30M | $14.50M | $8.30M | $453.40M | -$154.20M |
| Financing cash flow | $6.20M | $154.30M | $266.20M | $98.70M | $139.30M | $73.80M | -$343.00M | -$442.10M | $83.20M | $148.70M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $218.50M | $92.30M | -$86.20M | $116.50M | $100.40M | $2.60M | -$110.60M | -$3.40M | -$15.50M | $66.50M | $66.50M | -$7.50M |
| Capital expenditures | $11.80M | $38.30M | $13.20M | $12.70M | $8.40M | $13.60M | $17.60M | $25.00M | $16.70M | $15.00M | $15.00M | $31.50M |
| Free cash flow | $206.70M | $54.00M | -$99.40M | $103.80M | $92.00M | -$11.00M | -$128.20M | -$28.40M | -$32.20M | $51.50M | $51.50M | -$39.00M |
Frequently Asked Questions About CLMT
What is Calumet Specialty Products Partners' annual revenue?
Calumet Specialty Products Partners reported revenue of $4.14B for the fiscal year ended Dec 31, 2025.
How fast is Calumet Specialty Products Partners' revenue growing?
Revenue was down 1.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -4.1%.
Is Calumet Specialty Products Partners profitable?
No. Calumet Specialty Products Partners reported net income of -$33.80M for the fiscal year ended Dec 31, 2025, with a net margin of -0.8%.
How much free cash flow does CLMT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $108.90M minus capital expenditures of $52.30M produced free cash flow of $56.60M.
How much debt does Calumet Specialty Products Partners have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.08B, short-term debt of $220.40M and cash and equivalents of $125.10M.
CLMT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors